February 27, 2026

Novel Therapies and Multidisciplinary Strategies in Metastatic Triple-Positive Breast Cancer

Explore the latest insights on treating metastatic triple-positive breast cancer, emphasizing multimodal therapy and adverse event management, as discussed by oncology experts at JADPRO Live 2025.

JADPRO

February 26, 2026

AI Meets Molecular Testing in Thyroid Nodules

This combined approach has the potential to improve patient outcomes ... without negatively impacting long-term cancer-related outcomes.”

Conexiant

February 25, 2026

AI Tools Expand in Thyroid Cancer Diagnosis

Uptake will require “compelling evidence that these systems can reduce time and effort while at least maintaining, if not improving, diagnostic accuracy, making the cost of implementation and continued usage worthwhile.”

Conexiant

February 25, 2026

Meeting the GLP-1 Challenge with High-Resolution Mass Spec

Veloxity Labs and SCIEX team up to advance peptide bioanalysis; here, the teams discuss how the GLP-1 boom is reshaping workflows and raising the bar for analytical performance

The Analytical Scientist

February 25, 2026

Human-Relevant Discovery: iPSC Models and the Future of Rare Disease R&D

A Q&A with iXCells Biotechnologies CEO, Steve Smith

The Medicine Maker

February 17, 2026

Exercise Matters Following Cancer

Postdiagnosis physical activity was associated with lower cancer mortality across several cancer types.

Conexiant

February 17, 2026

Hospital Prices Posted. Few Patients Look.

Federal rules require hospitals to post prices so patients can shop. Instead, insurers and providers use the data to negotiate what they get paid.

KFF Health News

February 16, 2026

The Molecular Secret to Spider Silk’s Strength 

AlphaFold3 and DNP-enhanced NMR reveal key residue-level interactions in dragline silk

The Analytical Scientist

February 13, 2026

Bracco Targets Cell Therapy Manufacturing with Bead-Free Microbubble Cell Processing

Bead-free microbubble approach aims to simplify cell selection and activation for scalable cell therapy manufacturing

The Medicine Maker